1,000
Participants
Start Date
November 17, 2019
Primary Completion Date
October 30, 2025
Study Completion Date
October 30, 2025
Vitamin B3
ELICIT Study: Factorial design RCT of nicotinamide (vitamin B3) to mothers and infants, and antimicrobial prophylaxis (Azithromycin) to infants.
Azithromycin
"ELICIT Study: Factorial design RCT of nicotinamide (vitamin B3) to mothers and infants, and antimicrobial prophylaxis (Azithromycin) to infants.~VITAL Pakistan Study: 3-arm RCT of fortified food supplement (protein energy) during lactation, with or without azithromycin prophylaxis for infant."
Fortified food supplement
"VITAL Study: 3-arm RCT of fortified food supplement (protein energy) during lactation, with or without azithromycin prophylaxis for infant.~MISAMEIII Study: 2x2 cross-over efficacy RCT of fortified food supplement (folic acid/iron +/- peanut spread) during pregnancy and/or lactation; unmasked (open label)."
Manitoba Interdisciplinary Lactation Centre (MILC), Winnipeg
Collaborators (2)
Bill and Melinda Gates Foundation
OTHER
Stanford University
OTHER
The University of Western Australia
OTHER
University of Idaho
OTHER
Ludwig-Maximilians - University of Munich
OTHER
Johns Hopkins University
OTHER
Cedars-Sinai Medical Center
OTHER
Sapient Bioanalytics
UNKNOWN
University of California, Davis
OTHER
University of California, San Diego
OTHER
University of Virginia
OTHER
Aga Khan University
OTHER
University Ghent
OTHER
University of California, Berkeley
OTHER
University Health Network, Toronto
OTHER
USDA Beltsville Human Nutrition Research Center
FED
Antigen Discovery Inc
UNKNOWN
USDA, Western Human Nutrition Research Center
FED
University of Manitoba
OTHER